University Medical Center Groningen: Melanoma trials

The registry lists 13 Melanoma studies with University Medical Center Groningen as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 1Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.RecruitingNCT07206017Not applicable
• POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint InhibitorsRecruitingNCT04193956
• Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICGStatus unknownNCT05467137Phase 4
• Quality of Life and Physical Fitness After Immune Checkpoint InhibitorsCompletedNCT03946007
• PD-L1 PET Imaging in Melanoma PatientsCompletedNCT03520634Not applicable
• Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma PatientsCompletedNCT02949154
• IL2 Imaging in Metastatic MelanomaTerminatedNCT02922283Not applicable
• Pembrolizumab-PET ImagingCompletedNCT02760225Not applicable
• [18F]Dabrafenib Molecular Imaging in Melanoma Brain MetastasisTerminatedNCT02700763Not applicable
• Nivo/Ipi Combination Therapy in Symptomatic Brain MetastasesTerminatedNCT02621515Phase 2
• Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With PembrolizumabCompletedNCT02600169
• Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.CompletedNCT02600143
• Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II MelanomaStatus unknownNCT01018004